Actively Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Led by RenJi Hospital · Updated on 2025-10-03
10000
Participants Needed
1
Research Sites
1047 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
CONDITIONS
Official Title
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 and over
You will not qualify if you...
- Does not cooperate in signing the informed consent form
- Does not possess legal capacity
- In a state of loss of consciousness
- Suffering from severe mental illness, unable to communicate normally
- Having a disease that affects study assessments and is unsuitable for inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Shanghai, China
Actively Recruiting
Research Team
融
融 黄, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here